Latest News

  • RESEARCH

    13 Feb 2026

    Core-Shell LNP Study Signals Promise, Not Proof

  • REGULATORY

    12 Feb 2026

    FDA Aligns Device Rules With Global Standard

  • INNOVATION

    11 Feb 2026

    Smart Microneedle Patches Reshape Drug Delivery

  • PARTNERSHIPS

    10 Feb 2026

    Integrated CDMO Alliance Targets Oral Drug Timelines

A New Sound in Clot Treatment Draws Fresh Capital

Gloved hands holding a thin medical catheter used in vascular procedures

INVESTMENT

9 Feb 2026

SonoVascular’s $6M raise highlights rising interest in investigational ultrasound tools aimed at safer, more targeted clot treatment

Modern drug research laboratory with researchers conducting experiments

MARKET TRENDS

5 Feb 2026

Why Targeted Drug Delivery Is Redrawing Pharma Playbooks

Targeted delivery is shaping how US drugmakers plan R&D, especially in cancer and complex biologics, as precision becomes central to v...

Researchers reviewing artificial intelligence models displayed on a digital screen

TECHNOLOGY

4 Feb 2026

FDA Signals Cautious Opening for AI in Drug Development

FDA draft guidance from 2025 and voluntary 2026 AI principles point to growing openness, offering direction but not yet firm rules for dru...

GlaxoSmithKline headquarters building

PARTNERSHIPS

3 Feb 2026

GSK’s $2.2B Allergy Bet Heats Up the Immunology Race

GSK’s acquisition of RAPT sharpens its immunology pipeline and raises the stakes in next-generation allergy treatments

Cl ose-up of a tiny implant device inspected during drug delivery research

INSIGHTS

2 Feb 2026

A $20M Bet That Brain Implants Can Fix Drug Failure

CraniUS Therapeutics’ $20M raise highlights implant-based delivery as a potential solution to the brain access challenge shaping neurology...

Light activated microneedle drug delivery patch shown in laboratory research

RESEARCH

30 Jan 2026

A Flash of Light, No Injection Required

Early pre-clinical studies suggest light-triggered microneedle patches could one day reduce reliance on injections, pending further valida...

US Food and Drug Administration logo on exterior signage

REGULATORY

29 Jan 2026

Can FDA’s Softer Rules Spark a Cell Therapy Boom?

New FDA flexibility on manufacturing may ease deal friction and shape future M&A in cell and gene therapy

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.